https://doi.org/10.1200/jco.22.01565
M
Marieke E. Straver
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
61
Papers
4.9K
Citations
22
h-index
29
i10-index
Marieke E. Straver is an academic researcher from Medisch Centrum Haaglanden. The author has contributed to research in topics: Breast Cancer Treatment Studies & Breast Lesions and Carcinomas & Breast Implant and Reconstruction. The author has an h-index of 22, co-authored 52 publications.
ORCID: 0000-0003-3052-318XPapers by this author
worksRadiotherapy or Surgery of the Axilla After a Positive Sentinel Node in Breast Cancer: 10-Year Results of the Randomized Controlled EORTC 10981-22023 AMAROS Trial
2022 · Journal of Clinical Oncology · 330 citations
Concordance of clinical and molecular breast cancer subtyping in the context of preoperative chemotherapy response
2009 · Breast Cancer Research and Treatment · 169 citations
https://doi.org/10.1007/s10549-009-0499-6
The Relevance of Breast Cancer Subtypes in the Outcome of Neoadjuvant Chemotherapy
2010 · Annals of Surgical Oncology · 134 citations
https://doi.org/10.1245/s10434-010-1008-1
Feasibility of FDG PET/CT to monitor the response of axillary lymph node metastases to neoadjuvant chemotherapy in breast cancer patients
2010 · European Journal of Nuclear Medicine and Molecular Imaging · 80 citations
https://doi.org/10.1007/s00259-009-1343-2
Acute toxicity of intraoperative radiotherapy and external beam-accelerated partial breast irradiation in elderly breast cancer patients
2018 · Breast Cancer Research and Treatment · 19 citations
https://doi.org/10.1007/s10549-018-4712-3
Characterisation of multifocal breast cancer using the 70-gene signature in clinical low-risk patients enrolled in the EORTC 10041/BIG 03-04 MINDACT trial
2017 · European Journal of Cancer · 15 citations
https://doi.org/10.1016/j.ejca.2017.03.034
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat